Uncoupling the Folding and Binding of an Intrinsically Disordered Protein - PubMed
- ️Mon Jan 01 2018
Uncoupling the Folding and Binding of an Intrinsically Disordered Protein
Anusha Poosapati et al. J Mol Biol. 2018.
Abstract
The relationship between helical stability and binding affinity was examined for the intrinsically disordered transactivation domain of the myeloblastosis oncoprotein, c-Myb, and its ordered binding partner, KIX. A series of c-Myb mutants was designed to either increase or decrease helical stability without changing the binding interface with KIX. This included a complimentary series of A, G, P, and V mutants at three non-interacting sites. We were able to use the glycine mutants as a reference state and show a strong correlation between binding affinity and helical stability. The intrinsic helicity of c-Myb is 21%, and helicity values of the mutants ranged from 8% to 28%. The c-Myb helix is divided into two conformationally distinct segments. The N-terminal segment, from K291-L301, has an average helicity greater than 60% and the C-terminal segment, from S304-L315, has an average helicity less than 10%. We observed different effects on binding when these two segments were mutated. Mutants in the N-terminal segment that increased helicity had no effect on the binding affinity to KIX, while helix destabilizing glycine and proline mutants reduced binding affinity by more than 1 kcal/mol. Mutants that either increased or decreased helical stability in the C-terminal segment had almost no effect on binding. However, several of the mutants reveal the presence of multiple conformations accessible in the bound state based on changes in enthalpy and linkage analysis of binding free energies. These results may explain the high level of sequence identity (>90%), even at non-interacting sites, for c-Myb homologues.
Keywords: binding affinity; c-Myb transactivation domain; coupled folding and binding; fractional helicity; intrinsically disordered protein.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Figures

Molar residue ellipticity is plotted against wavelength. The black curve shows the molar residue ellipticity of WT c-Myb TAD. Grey curves show the molar residue ellipticity for G311A, P289A, and P289A/P316A. Molar residue ellipticity values in the figure are the mean of two CD measurements collected using the same sample.

Black circles show enthalpy per mole of injectant, measured using isothermal titration calorimetry, plotted as a function of [c-Myb TAD]/[KIX]. Black lines show the fit to the data obtained using a single site binding model. Shown here is the binding of A) WT c-Myb TAD to KIX B) c-Myb P289A to KIX and C) c-Myb P289A P316A to KIX.

Plots showing alpha carbon secondary chemical shifts (ΔδCα, black bars) and the percent helicity values calculated using δ2d (red lines) for WT and the proline mutants of c-Myb TAD. Blue lines in B and C show overlay of WT δ2d values. X-axis shows the amino acid sequence with mutation sites in red font. A) ΔδCα and δ2d plots for WT c-Myb TAD, B) ΔδCα and δ2d plots for P289A, and C) ΔδCα and δ2d plots for P289A/P316A.

A) c-Myb TAD residues shown in blue form an alpha helix and are in direct contact with the KIX residues shown in green. Other c-Myb TAD residues shown form an alpha helix and do not make direct contact with KIX. Residues shown in red selected for mutagenesis. B) Structure of the c-Myb TAD-KIX complex (PDB ID 1SB0). A surface model of KIX is shown in green and c-Myb TAD is shown as a ribbon structure in red. Side chains are shown for solvent-exposed amino acid residues that do not directly contact KIX.

Molar residue ellipticity is plotted against wavelength. In each panel the black curve shows the molar residue ellipticity of WT c-Myb TAD and grey curves show the mutants. A) CD spectra for L300 mutants. B) CD spectra for S304 mutants. C) CD spectra for N307 mutants. D) CD spectra for charge mutants. Molar residue ellipticity values in the figure are the mean of two CD measurements collected using the same sample.

Black circles show enthalpy per mole of injectant, measured using isothermal titration calorimetry, plotted as a function of [c-Myb TAD]/[KIX]. Black lines show the fit to the data obtained using a single site binding model. Shown here is the binding of a) L300V to KIX b) L300G to KIX and C) L300P to KIX.

Plots showing alpha carbon secondary chemical shifts (ΔδCα, black bars) and the percent helicity values calculated using δ2d (red lines) for L300 mutants. Blue lines in A and B show overlay of WT δ2d values. X-axis shows the amino acid sequence with mutation sites in red font. A) ΔδCα and δ2d plots for L300G, B) ΔδCα and δ2d plots for L300P.

Calculation of average amide nitrogen and proton chemical shift changes for KIX is described in the materials and methods. The plots show residue specific chemical shift changes of A) KIX binding to WT cMyb TAD and B) KIX binding to L300G and C) KIX binding to L300P. Asterisks label KIX residues that directly contact c-Myb TAD in the solution structure. The average combined resolution for the 1H and 15N dimensions in the HSQC was 0.03 ppm. Chemical shift changes greater than this value are considered.

A) Correlation plot of the average chemical shift changes for KIX when bound to either L300G or WT c-Myb TAD. B) Correlation plot of the average chemical shift changes for KIX when bound to either L300P or WT c-Myb TAD. C) Overlay of 1H-15N HSQC resonances for Y640. D) Overlay of 1H-15N HSQC resonances for K633. In B) and C) blue peaks are from free KIX, red peaks are from KIX bound to WT c-Myb TAD, green peaks are from KIX bound to L300G, and magenta peaks are from KIX bound to L300P

A) Plot of binding free energy (ΔG) from ITC is versus percent helicity values for residues 289–316. B) Expanded version of A with labels for each data point. Blue points show mutants that may change the structure of the c-Myb/KIX complex. C) Plot of helical stability versus ΔΔG of binding. The ΔG of binding for the glycine mutants was subtracted from the values of WT and the A, V, and P mutants at each site. Helical stability is plotted a percent helicity of a glycine mutant at a given position divided by the percent helicity of the WT and the A, V, and P mutants at the same site. The S304V mutant was excluded from the plot.
Similar articles
-
Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.
Suetaka S, Oka Y, Kunihara T, Hayashi Y, Arai M. Suetaka S, et al. Sci Rep. 2022 Jan 20;12(1):816. doi: 10.1038/s41598-021-04497-w. Sci Rep. 2022. PMID: 35058484 Free PMC article.
-
Arai M, Sugase K, Dyson HJ, Wright PE. Arai M, et al. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9614-9. doi: 10.1073/pnas.1512799112. Epub 2015 Jul 20. Proc Natl Acad Sci U S A. 2015. PMID: 26195786 Free PMC article.
-
Giri R, Morrone A, Toto A, Brunori M, Gianni S. Giri R, et al. Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14942-7. doi: 10.1073/pnas.1307337110. Epub 2013 Aug 26. Proc Natl Acad Sci U S A. 2013. PMID: 23980173 Free PMC article.
-
Affinity versus specificity in coupled binding and folding reactions.
Gianni S, Jemth P. Gianni S, et al. Protein Eng Des Sel. 2019 Dec 31;32(8):355-357. doi: 10.1093/protein/gzz020. Protein Eng Des Sel. 2019. PMID: 31397874 Review.
-
What lessons can be learned from studying the folding of homologous proteins?
Nickson AA, Clarke J. Nickson AA, et al. Methods. 2010 Sep;52(1):38-50. doi: 10.1016/j.ymeth.2010.06.003. Epub 2010 Jun 4. Methods. 2010. PMID: 20570731 Free PMC article. Review.
Cited by
-
The sequence-ensemble relationship in fuzzy protein complexes.
Hadži S, Loris R, Lah J. Hadži S, et al. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2020562118. doi: 10.1073/pnas.2020562118. Proc Natl Acad Sci U S A. 2021. PMID: 34504009 Free PMC article.
-
A disordered encounter complex is central to the yeast Abp1p SH3 domain binding pathway.
Gerlach GJ, Carrock R, Stix R, Stollar EJ, Ball KA. Gerlach GJ, et al. PLoS Comput Biol. 2020 Sep 14;16(9):e1007815. doi: 10.1371/journal.pcbi.1007815. eCollection 2020 Sep. PLoS Comput Biol. 2020. PMID: 32925900 Free PMC article.
-
Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.
Suetaka S, Oka Y, Kunihara T, Hayashi Y, Arai M. Suetaka S, et al. Sci Rep. 2022 Jan 20;12(1):816. doi: 10.1038/s41598-021-04497-w. Sci Rep. 2022. PMID: 35058484 Free PMC article.
-
Calcium Solubilization Ability and Anti-Inflammatory Effects of Hydrolyzed Casein.
Kim DY, Yoo JS, Cho YA, Yoon HS, Kim CH. Kim DY, et al. Food Sci Anim Resour. 2021 Jul;41(4):687-700. doi: 10.5851/kosfa.2021.e29. Epub 2021 Jul 1. Food Sci Anim Resour. 2021. PMID: 34291216 Free PMC article.
-
Borcherds WM, Daughdrill GW. Borcherds WM, et al. Methods Enzymol. 2018;611:101-136. doi: 10.1016/bs.mie.2018.09.011. Epub 2018 Oct 22. Methods Enzymol. 2018. PMID: 30471686 Free PMC article.
References
-
- Dyson HJ. Coupled Folding and Binding. In: Roberts GCK, editor. Encyclopedia of Biophysics. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. pp. 381–5.
-
- Dyson HJ, Wright PE. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol. 2002;12:54–60. - PubMed
-
- Gianni S, Dogan J, Jemth P. Coupled binding and folding of intrinsically disordered proteins: what can we learn from kinetics? Curr Opin Struct Biol. 2016;36:18–24. - PubMed
-
- Mendoza-Espinosa P, Garcia-Gonzalez V, Moreno A, Castillo R, Mas-Oliva J. Disorder-to-order conformational transitions in protein structure and its relationship to disease. Mol Cell Biochem. 2009;330:105–20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources